Cargando…

Performance and modification of EGCRISC among hepatitis C virus high-risk groups

We have previously shown that the Egyptian Hepatitis C Virus Risk Score (EGCRISC), an Egyptian hepatitis C virus (HCV) risk-based screening tool, to be valid and cost-effective. Certain behaviours, occupations and diseases have been shown to be associated with an increased risk of exposure to HCV in...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Ghitany, E. M., Alkassabany, Y. M., Farghaly, A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026894/
https://www.ncbi.nlm.nih.gov/pubmed/32054561
http://dx.doi.org/10.1017/S0950268820000175
_version_ 1783498758347030528
author El-Ghitany, E. M.
Alkassabany, Y. M.
Farghaly, A. G.
author_facet El-Ghitany, E. M.
Alkassabany, Y. M.
Farghaly, A. G.
author_sort El-Ghitany, E. M.
collection PubMed
description We have previously shown that the Egyptian Hepatitis C Virus Risk Score (EGCRISC), an Egyptian hepatitis C virus (HCV) risk-based screening tool, to be valid and cost-effective. Certain behaviours, occupations and diseases have been shown to be associated with an increased risk of exposure to HCV infection and constitute a major population reservoir of HCV infection. This study investigated the efficacy of EGCRISC in selected high-risk groups by testing 863 participants from four groups: slaughterhouse workers, illicit drug users (IDUs), female sex workers and human immune deficiency virus (HIV) patients. Data for this study were collected on EGCRISC and another pre-designed risk factor questionnaire. Sera were tested for HCV antibodies by ELISA. EGCRISC, at lower cut-off points, showed significantly good performance (P < 0.05) in all four groups except for females <45 years, but was reliable in detecting HCV cases (sensitivity: 84.21% and negative predictive value: 94.5%). Specific scores for IDUs and HIV patients were developed that showed high accuracy (P < 0.001). A modified EGCRISC for high-risk groups (EGCRISC-HRGs) was shown to be a valid tool that is recommended for use in high-risk populations if no other specific screening tool is available or universal screening is applied. EGCRISC for IDUs (EGCRISC-IDUs) and EGCRISC for HIV patients (EGCRISC-HIV) are useful tools for preselecting potentially HCV-infected cases for further testing in settings where serological analysis is not readily available or accessible.
format Online
Article
Text
id pubmed-7026894
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-70268942020-02-28 Performance and modification of EGCRISC among hepatitis C virus high-risk groups El-Ghitany, E. M. Alkassabany, Y. M. Farghaly, A. G. Epidemiol Infect Original Paper We have previously shown that the Egyptian Hepatitis C Virus Risk Score (EGCRISC), an Egyptian hepatitis C virus (HCV) risk-based screening tool, to be valid and cost-effective. Certain behaviours, occupations and diseases have been shown to be associated with an increased risk of exposure to HCV infection and constitute a major population reservoir of HCV infection. This study investigated the efficacy of EGCRISC in selected high-risk groups by testing 863 participants from four groups: slaughterhouse workers, illicit drug users (IDUs), female sex workers and human immune deficiency virus (HIV) patients. Data for this study were collected on EGCRISC and another pre-designed risk factor questionnaire. Sera were tested for HCV antibodies by ELISA. EGCRISC, at lower cut-off points, showed significantly good performance (P < 0.05) in all four groups except for females <45 years, but was reliable in detecting HCV cases (sensitivity: 84.21% and negative predictive value: 94.5%). Specific scores for IDUs and HIV patients were developed that showed high accuracy (P < 0.001). A modified EGCRISC for high-risk groups (EGCRISC-HRGs) was shown to be a valid tool that is recommended for use in high-risk populations if no other specific screening tool is available or universal screening is applied. EGCRISC for IDUs (EGCRISC-IDUs) and EGCRISC for HIV patients (EGCRISC-HIV) are useful tools for preselecting potentially HCV-infected cases for further testing in settings where serological analysis is not readily available or accessible. Cambridge University Press 2020-02-14 /pmc/articles/PMC7026894/ /pubmed/32054561 http://dx.doi.org/10.1017/S0950268820000175 Text en © The Author(s) 2020 http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
El-Ghitany, E. M.
Alkassabany, Y. M.
Farghaly, A. G.
Performance and modification of EGCRISC among hepatitis C virus high-risk groups
title Performance and modification of EGCRISC among hepatitis C virus high-risk groups
title_full Performance and modification of EGCRISC among hepatitis C virus high-risk groups
title_fullStr Performance and modification of EGCRISC among hepatitis C virus high-risk groups
title_full_unstemmed Performance and modification of EGCRISC among hepatitis C virus high-risk groups
title_short Performance and modification of EGCRISC among hepatitis C virus high-risk groups
title_sort performance and modification of egcrisc among hepatitis c virus high-risk groups
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026894/
https://www.ncbi.nlm.nih.gov/pubmed/32054561
http://dx.doi.org/10.1017/S0950268820000175
work_keys_str_mv AT elghitanyem performanceandmodificationofegcriscamonghepatitiscvirushighriskgroups
AT alkassabanyym performanceandmodificationofegcriscamonghepatitiscvirushighriskgroups
AT farghalyag performanceandmodificationofegcriscamonghepatitiscvirushighriskgroups